Baolingbao Biology Co.,Ltd. (SHE:002286)

China flag China · Delayed Price · Currency is CNY
10.17
-0.01 (-0.10%)
Apr 29, 2026, 3:04 PM CST
24.79%
Market Cap 3.87B
Revenue (ttm) 2.81B
Net Income (ttm) 154.40M
Shares Out 380.57M
EPS (ttm) 0.41
PE Ratio 24.64
Forward PE n/a
Dividend 0.12 (1.18%)
Ex-Dividend Date Jul 3, 2025
Volume 8,465,302
Average Volume 7,966,868
Open 10.28
Previous Close 10.18
Day's Range 10.11 - 10.34
52-Week Range 8.15 - 13.40
Beta 0.59
RSI 51.55
Earnings Date Apr 25, 2026

About Baolingbao Biology

Baolingbao Biology Co.,Ltd. researches and develops, manufactures, and sells a range of functional sugars in China. The company offers prebiotics, such as isomaltooligosaccharides, galactooligosaccharides, fructooligosaccharides, bagasse trisaccharides, and xylooligosaccharides; sugar alcohols and new sugar source products, including erythritol, trehalose, crystalline fructose, alodonose, and maltose; dietary fiber products comprising polydextrose and resistant dextrin; modified, waxy maize, and corn starch products; starch sugar products, incl... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1997
Employees 1,395
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002286
Full Company Profile

Financial Performance

In 2025, Baolingbao Biology's revenue was 2.75 billion, an increase of 14.54% compared to the previous year's 2.40 billion. Earnings were 150.63 million, an increase of 35.50%.

Financial Statements

News

There is no news available yet.